Avoid CMC Challenges by Thinking Slow, Not Fast-Discussions at USP’s Workshop
The FDA Law Blog
NOVEMBER 1, 2022
Brevig, Senior Regulatory Device and Biologics Expert — On October 26, 2022, US Pharmacopeia (USP) Biologics Stakeholder Forum held a workshop on “Collaborating to solve CMC challenges and support efficient development of lentiviral-mediated CART cell therapies.” Opportunity for feedback from FDA if provided pre-BLA. By Holly N.
Let's personalize your content